Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
UTI Medium Duration Fund - Direct Plan - Quarterly IDCW
★★★★★ TopFund est.
TopFund Score (fallback rating)
- Calculated by: TopFund — used only when no third-party rating exists for this fund
- Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis
TopFund Score: 62/100 · Average
How this score is calculated
- Star rating (35%)3/5
- 3Y CAGR (30%)7.01%
- Expense ratio (20%)0.83%
- AUM (15%)₹3,280 Cr
Not investment advice — an analytical read of public fund data. Methodology →
UTI Mutual Fund · Income/Debt Oriented · Medium Term Fund
₹15.55
AUM: ₹3,280 Cr
NAV updated 13 days ago
Plan
Direct
Option
Idcw
Risk
Moderate
Expense Ratio
0.83%
Exit Load
Exit load of 1%, if redeemed within 1 Year.
Fund Manager
Mohit Sharma
Inception
Jan 2013
Benchmark
CRISIL Medium Duration Debt A-III Index
Sharpe Ratio
-0.73
Std Dev (1Y)
1.38%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
-0.16%
3m
+1.52%
6m
+2.43%
1y
+5.24%
3y
+7.01%
5y
+6.04%
10y
+3.75%
since inception
+3.92%
TopFund's Take on UTI Medium Duration Fund - Direct Plan - Quarterly IDCW
UTI Medium Duration Fund - Direct Plan - Quarterly IDCW sits in the middle of the pack for Medium Term Fund funds, currently carrying a 3-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 62/100.
Cost: At 0.83%, the expense ratio runs 12% above the Medium Term Fund category average of 0.74%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.73 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 1.38% is on the lower side for a Medium Term Fund fund, suggesting a comparatively smoother ride.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Income/Debt Oriented fund.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Tools & Guides for This Fund
Frequently Asked Questions about UTI Medium Duration Fund - Direct Plan - Quarterly IDCW
The current NAV (Net Asset Value) of UTI Medium Duration Fund - Direct Plan - Quarterly IDCW is ₹15.55. NAV is updated every business day after market close by AMFI.
1Y: 5.24% · 3Y CAGR: 7.01% · 5Y CAGR: 6.04%
The expense ratio of UTI Medium Duration Fund - Direct Plan - Quarterly IDCW is 0.83% per annum. This is the annual fee charged by the fund to manage your investment.
UTI Medium Duration Fund - Direct Plan - Quarterly IDCW is managed by Mohit Sharma at UTI Mutual Fund.
UTI Medium Duration Fund - Direct Plan - Quarterly IDCW is classified as a Moderate risk fund. It is suitable for investors with a moderate risk appetite.
UTI Medium Duration Fund - Direct Plan - Quarterly IDCW is a Medium Term Fund fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in UTI Medium Duration Fund - Direct Plan - Quarterly IDCW with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of UTI Medium Duration Fund - Direct Plan - Quarterly IDCW is ₹3,280 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.